Inadvertent radical nephrectomy leads to worse prognosis in renal pelvic urothelial carcinoma patients: A propensity score-matched study

Feixiang Wu, Pan Zhang, Lingxun Li, Shiqing Lin, Jianhong Liu, Yi Sun, Yuanlong Wang, Chengjun Luo, Yu Huang, Xiao Yan, Meng Zhang, Guixi Liu, Kun LiFrontiers in Oncology 2022 · DOI

This study, published in Frontiers in Oncology, investigates a critical diagnostic pitfall in urology: the misidentification of renal pelvic urothelial carcinoma (RPUC) as common kidney cancer (renal cell carcinoma), and the subsequent impact of performing the "wrong" surgery on patient survival.

TL;DR

When a tumor in the renal pelvis is misdiagnosed as renal cell carcinoma, surgeons may perform a radical nephrectomy (RN) instead of the gold-standard radical nephroureterectomy (NU). This study demonstrates that this surgical "under-treatment" significantly worsens overall survival, particularly for patients with tumors larger than 4.2 cm.

What Problem Does This Paper Address?

There are two main types of cancer that occur in the kidney area: Renal Cell Carcinoma (RCC), which originates in the kidney tissue itself, and Renal Pelvic Urothelial Carcinoma (RPUC), which starts in the lining of the drainage system.

The standard of care for RCC is a Radical Nephrectomy (RN)—removing the kidney. However, RPUC is "multifocal," meaning it is highly likely to recur in the ureter (the tube connecting the kidney to the bladder). Therefore, RPUC requires a Radical Nephroureterectomy (NU), which removes the kidney, the entire ureter, and a small cuff of the bladder.

The challenge is that these two cancers can look nearly identical on CT or MRI scans. Because biopsies are often avoided in suspected kidney cancer to prevent "seeding" the tumor, surgeons sometimes perform an RN, only to find out from the pathology report days later that the patient actually had RPUC. This study asks: how much does this diagnostic error actually hurt the patient's long-term prognosis?

Methods

The researchers conducted a retrospective cohort study using data from the Surveillance, Epidemiology, and End Results (SEER) database. To ensure a fair comparison between patients who received the "correct" surgery (NU) and those who received the "inadvertent" surgery (RN), they employed Propensity Score Matching (PSM).

PSM is a statistical technique that mimics a randomized controlled trial by pairing patients from both groups who have similar baseline characteristics (like age, race, and tumor stage). This helps isolate the effect of the surgical method itself rather than differences in the patients' health status. They also used a tool called X-tile to determine the optimal "cutoff" point for tumor size to see if the impact of the surgery changed as tumors grew larger.

Datasets

The study utilized the SEER database, a premier source for cancer statistics in the U.S. They identified 2,197 cases diagnosed between 2004 and 2017:

  • 2,010 patients received the standard Radical Nephroureterectomy (NU).
  • 187 patients received an inadvertent Radical Nephrectomy (RN).

Key Insights and Ideas

  • The "Ureter Problem": The primary reason RN leads to worse outcomes is the "incomplete" nature of the surgery. By leaving the ureter behind, the surgeon leaves a "field" where the urothelial cancer is likely to return.
  • Size Matters: The most striking insight is that the negative impact of the wrong surgery isn't uniform. For small tumors (≤4.2 cm), the difference in survival between the two surgeries was not statistically significant.
  • The Diagnostic Gap: The study highlights a major limitation in current preoperative imaging. Because RPUC can infiltrate the kidney tissue (mimicking RCC), imaging alone is often insufficient, leading to an 8.5% "error rate" in surgical selection in this cohort.

Key Results

  • Overall Survival (OS): Before matching, patients who received the "wrong" surgery (RN) had significantly worse survival (Hazard Ratio [HR]: 1.444). After matching for confounders, the RN group still faced a significantly higher risk of death (HR: 1.298, p = 0.048).
  • Cancer-Specific Survival (CSS): While the RN group had worse cancer-specific outcomes before matching, the difference became statistically non-significant in the matched group overall (p = 0.282).
  • The 4.2 cm Threshold: In the hierarchical analysis, patients with tumors larger than 4.2 cm who received RN had drastically worse outcomes for both Overall Survival (HR: 1.545) and Cancer-Specific Survival (HR: 1.607) compared to those who received the correct NU surgery.

Limitations and Future Work

The authors acknowledge several limitations inherent to using the SEER database:

  1. Missing Recurrence Data: SEER tracks survival but not whether the cancer returned in the remaining ureter, which is the hypothesized mechanism for the worse outcomes.
  2. Retrospective Bias: Even with propensity matching, a retrospective study cannot account for all "hidden" variables that might influence a surgeon's decision in the operating room.
  3. Clinical Detail: The database lacks specific details on preoperative hydronephrosis (kidney swelling) or the exact surgical margins, both of which are important prognostic factors.

Future Work: The authors suggest that for patients with large, centrally located renal masses where the diagnosis is ambiguous, clinicians should consider more invasive diagnostic steps—such as ureteroscopy or biopsy—to ensure the correct surgical path is chosen from the start.

Summary updated

Abstract

RN could lead to worse oncological outcomes than NU in patients with renal pelvis urothelial carcinoma. Accurate diagnosis of renal pelvis urothelial carcinoma is extremely important.
BibTeX
@inproceedings{wu2022inadvertent,
  author = {Feixiang Wu and Pan Zhang and Lingxun Li and Shiqing Lin and Jianhong Liu and Yi Sun and Yuanlong Wang and Chengjun Luo and Yu Huang and Xiao Yan and Meng Zhang and Guixi Liu and Kun Li},
  title = {{Inadvertent radical nephrectomy leads to worse prognosis in renal pelvic urothelial carcinoma patients: A propensity score-matched study}},
  booktitle = {Frontiers in Oncology},
  year = {2022},
  doi = {10.3389/fonc.2022.948223},
}
Figure